| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 01/04/2012 | CN102304104A TRPV1 (transient receptor potential cation channel, subfamily V, member 1) antagonists, and preparation method and medical application thereof |
| 01/04/2012 | CN102304087A Cucoline derivative as well as salts, preparation method and application thereof |
| 01/04/2012 | CN102304086A Heterocyclic inhibitors of MEK and methods of use thereof |
| 01/04/2012 | CN102304081A Green synthesis method for ibuprofen piconol and medicinal preparation thereof |
| 01/04/2012 | CN102302757A Osteodynia moxibustion patch |
| 01/04/2012 | CN102302753A Foot bath Chinese medicinal composition for treating heel pain of middle-aged and aged |
| 01/04/2012 | CN102302752A Traumatic injury plaster |
| 01/04/2012 | CN102302731A Traditional Chinese medicine composition for treating costalgia |
| 01/04/2012 | CN102302710A Chinese medicinal preparation for treating various arthralgia syndromes |
| 01/04/2012 | CN102302693A Method for extracting imperata cylindrical root extract |
| 01/04/2012 | CN102302653A Preparation method for total saponins of roots and rhizomes of disporum bodinieri and cantoniens |
| 01/04/2012 | CN102302640A Blood-activating and pain-relieving plaster, and preparation method thereof |
| 01/04/2012 | CN102302628A Medicament for treating lumbocrural pains and preparation method thereof |
| 01/04/2012 | CN102302615A Effective site group of daphne giraldii nitsche leaf, preparation method, medicinal composition and application thereof |
| 01/04/2012 | CN102302607A External Chinese medicinal preparation for treating wind-cold-dampness paralyses |
| 01/04/2012 | CN102302604A Traditional Chinese medicine (TCM) for treating arthritis |
| 01/04/2012 | CN102302603A External medicament for treating traumatic injury |
| 01/04/2012 | CN102302585A Chinese medicinal composition for treating arthralgia syndrome |
| 01/04/2012 | CN102302583A Medicinal composition for reducing swelling and alleviating pain |
| 01/04/2012 | CN102302578A Medicament capable of eliminating dampness and relieving numbness and preparation method thereof |
| 01/04/2012 | CN102302577A Medicinal liquor for treating rheumatoid arthritis |
| 01/04/2012 | CN102302565A Stasis eliminating powder for treating soft tissue injury and cervical spondylosis |
| 01/04/2012 | CN102302564A Pain stasis and paralysis eliminating powder for treating soft tissue injury |
| 01/04/2012 | CN102302561A Method for preparing belvedere fruit total saponins |
| 01/04/2012 | CN102302556A Extraction method of total flavonoid from coriaria sinica maxim |
| 01/04/2012 | CN102302555A Chinese medicinal extract for treating urarthritis, as well as preparation method and application thereof |
| 01/04/2012 | CN102302531A Preparation method of gnaphalium affine total flavonoid |
| 01/04/2012 | CN102302530A Medicinal liquor and preparation method thereof |
| 01/04/2012 | CN102302518A Cockroach extractive and prepared oral care composition as well as preparation method and applications |
| 01/04/2012 | CN102302498A Drug for treating nephritis |
| 01/04/2012 | CN102302494A Method using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias |
| 01/04/2012 | CN102302492A Methods and compositions for the treatment of neuropathic pain |
| 01/04/2012 | CN102302483A Application of flavonoid small molecule medicine in anti-inflammation and associated diseases |
| 01/04/2012 | CN102302478A Health-care medicine for treating various traumas |
| 01/04/2012 | CN102302460A Methylprednisolone sodium succinate freeze dried powder injection and preparation method thereof |
| 01/04/2012 | CN102302224A Nano-silver anionic far-infrared element fabric underwear for preventing and treating rheumatic arthritis |
| 01/04/2012 | CN102106928B Method for preparing high-purity oil tea saponins |
| 01/04/2012 | CN102048926B Chinese medicinal pain-relieving spray for externally treating osteoarthrosis |
| 01/04/2012 | CN102048924B Traditional Chinese medicine oral administration and external application combined preparation and application thereof |
| 01/04/2012 | CN101974011B New compound methyl brevicate with medical activity |
| 01/04/2012 | CN101972383B Wind-dispelling and damp-clearing wine |
| 01/04/2012 | CN101926833B Hydrogel patch and preparation method thereof |
| 01/04/2012 | CN101920017B Composite for promoting glycyrrhetinic acid to realize percutaneous permeation |
| 01/04/2012 | CN101856472B Production method of bone spur pain-eliminating capsule |
| 01/04/2012 | CN101816713B Garden balsam stem pain-relieving paste |
| 01/04/2012 | CN101791312B Use of tetrahydroisoquinoline derivatives |
| 01/04/2012 | CN101780145B Medical stone mineral health-care product |
| 01/04/2012 | CN101773551B External-use medicine composition of traditional Mongolian medicine for curing soft tissue injury |
| 01/04/2012 | CN101735168B P-sulfamyl benzylidene cyclic ketone compounds, preparation method and application thereof |
| 01/04/2012 | CN101716320B Externally applied medical composition for treating orthopedic diseases and preparation method thereof |
| 01/04/2012 | CN101643731B DDK-1 specific siRNA and application thereof in treatment of rheumatoid arthritis |
| 01/04/2012 | CN101618164B Pharmaceutical composition for curing rheumatoid arthritis |
| 01/04/2012 | CN101618069B Capsule preparation for treating bruise as well as bleeding and easing pain and preparation method and use thereof |
| 01/04/2012 | CN101461834B Cervus and cucumis polypeptide medicament composition oral preparation and preparation method thereof |
| 01/04/2012 | CN101444551B Rhizoma atractylodis arborinol inclusion compound, medicinal combination thereof and preparation method |
| 01/04/2012 | CN101410115B Compositions containing riboflavin and sesamin-class compounds |
| 01/04/2012 | CN101292741B Health care bamboo salt with mind pacifying and digestion promoting function, and method of preparing the same |
| 01/04/2012 | CN101199590B Lamiophlomis soft capsule containing micropowder silicagel and preparing method thereof |
| 01/03/2012 | US8088924 Pyridone derivatives having a binding activity to the cannabinoid type 2 receptor |
| 01/03/2012 | US8088910 Isolated multiple sclerosis (MS)-associated retrovirus (MSRV) nucleic acids corresponding to the gag region |
| 01/03/2012 | US8088906 FAD4, FAD5, FAD5-2, and FAD6, novel fatty acid desaturase family members and uses thereof |
| 01/03/2012 | US8088826 Tetrahydro-naphthalene derivatives |
| 01/03/2012 | US8088825 Fatty acid analogues for the treatment of inflammatory and autoimmune disorders |
| 01/03/2012 | US8088802 N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for its preparation |
| 01/03/2012 | US8088762 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 01/03/2012 | US8088383 Methods of therapy for B-cell malignancies using antagonist anti-CD40 antibodies |
| 01/03/2012 | US8088377 Human monoclonal antibodies against CD30 |
| 01/03/2012 | CA2690293C Methods for determining whether a compound is capable of inhibiting the interaction of a peptide with rage |
| 01/03/2012 | CA2662148C Phthalazine, aza- and diaza-phthalazine compounds and medicinal uses thereof |
| 01/03/2012 | CA2601508C Cyclopropanecarboxamide derivatives |
| 01/03/2012 | CA2496902C Medicament for activating the phagocytic capacity of macrophages |
| 01/03/2012 | CA2488565C Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom |
| 01/03/2012 | CA2480423C Truncated 24 kda basic fibroblast growth factor |
| 01/03/2012 | CA2468910C Use of 4-oxobutanoic acid derivatives in the treatment of inflammation |
| 01/03/2012 | CA2466054C Apo-2 ligand/trail formulations |
| 01/03/2012 | CA2465117C Lipoxins and their stable analogs in the treatment of asthma and inflammatory airway diseases |
| 01/03/2012 | CA2463134C Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles |
| 01/03/2012 | CA2457719C Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect |
| 01/03/2012 | CA2456717C Phenyl derivatives as factor xa inhibitors |
| 01/03/2012 | CA2455972C N6-benzyl and phenyl substituted adenines and their use as cosmetics, pharmaceutical preparations and plant growth regulators |
| 01/03/2012 | CA2436049C A serpin in bifidobacteria |
| 01/03/2012 | CA2428728C Combination antiperspirant and antimicrobial compositions |
| 01/03/2012 | CA2397661C 2,4-disubstituted thiazolyl derivatives |
| 01/03/2012 | CA2395684C Sulfonamides and derivatives thereof that modulate the activity of endothelin |
| 01/03/2012 | CA2227265C Methods and compositions useful for inhibition of .alpha.v.beta.5 mediated angiogenesis |
| 01/03/2012 | CA2222889C Improved formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents |
| 12/29/2011 | WO2011163614A2 Methods of treatment for esophageal inflammation |
| 12/29/2011 | WO2011163560A1 Methods of treatment using sterculic acid |
| 12/29/2011 | WO2011163539A2 nAChRα7 AGONISTS AND nAChRα7 ANTAGONISTS FOR TREATING ULCERATIVE COLITIS (UC) AND CROHN'S DISEASE (CD) |
| 12/29/2011 | WO2011163502A1 Derivatives of cycloalkyl- and cycloalkenyl-1,2-dicarboxylic acid compounds having formyl peptide receptor like-1 (fprl-1) agonist or antagonist activity |
| 12/29/2011 | WO2011163478A2 Dual variable domain immunoglobulins and uses thereof |
| 12/29/2011 | WO2011163308A2 Compositions and methods for preventing and treating organ injury and/or dysfunction |
| 12/29/2011 | WO2011162835A1 Imidazo[1,2-b][1,2,4]triazines as c-met inhibitors |
| 12/29/2011 | WO2011162409A1 Compounds having trpv1 antagonistic activity and uses thereof |
| 12/29/2011 | WO2011162320A1 Combination of egcg or methylated egcg and a pde inhibitor |
| 12/29/2011 | WO2011162300A1 Crystal of fused pyridine compound salt |
| 12/29/2011 | WO2011161615A1 5-lipoxygenase inhibitors |
| 12/29/2011 | WO2011161537A2 3,4-dihydropyrrolo[1,2-a]pyrazine-2,8(1h)-dicarboxamide derivatives, preparation thereof and therapeutic use thereof |
| 12/29/2011 | WO2011160845A2 Oxidized phospholipids and lipoproteins, and antibodies thereto, as biomarkers of inflammatory conditions and methods of treatment |
| 12/29/2011 | WO2011160189A1 METHOD OF SCREENING FOR INHIBITORS OF sPLA2-IIA |